Fundraising Fox
🦊/People
Sign in

Lucio Iannone

Investor

Managing Director at JDRF T1D Fund · Board director at Affini-T Therapeutics · Board director at Immunitas Therapeutics

Boston, Massachusetts, United States

Find your path to Lucio

349 people in our graph share verified history with Lucio — schools, employers, funds. One of them is your warm intro.

Deji SasegbonunlockedLucio: together at Imperial College London (2011–2014)
×2Lucio: together at Leaps by Bayer
×4Lucio: together at Imperial College London
×2Lucio: together at NextPoint Therapeutics

About

Lucio Iannone is a Senior Managing Director at T1D Fund, where he focuses on early-stage biotech investments. He works with scientists and entrepreneurs developing medical technologies and therapeutic applications.

Board director at Affini-T Therapeutics

Intro paths

→

In turn, Lucio can intro founders to Affini-T Therapeutics's investors below.

Affini-T Therapeutics's investors · 2

Leaps by BayerLeverkusen · since 2024Vida VenturesLos Angeles · since 2024

Board director at Immunitas Therapeutics

Intro paths

→

In turn, Lucio can intro founders to Immunitas Therapeutics's investors below.

Immunitas Therapeutics's investors · 10

Agent CapitalWaltham · since 2021DC Investment PartnersMcLean · $10M checks · since 2021Leaps by BayerLeverkusen · since 2021Longwood FundBoston · since 2021M VenturesLos Angeles · $10.8M checks · since 2021Medical Excellence CapitalNew York · since 2021MPM BioImpactBoston · $1M – $15M checks · since 2019Novartis Venture FundBasel · $5M – $25M checks · since 2021Ono Venture Investment, Inc.South San Francisco · since 2021Solasta VenturesBoston · since 2021

Experience

  1. T1D FundSr Managing Directorcurrent2025 — presentБостон, MA
  2. Amana Global PartnersSenior Investment Advisorcurrent2023 — present
  3. COUR PharmaBoard Observercurrent2025 — present
  4. Leaps by BayerHead of Venture Investments2021 — 2025Кембридж, MA
  5. Leaps by BayerSr Director of Venture Investments2017 — 2021Boston, Massachusetts
  6. Soufflé TherapeuticsBoard Member2023 — 2025
  7. Paratus SciencesBoard Member2022 — 2025Cambridge, Massachusetts, United States
  8. CellinoBoard Member2022 — 2025Cambridge, Massachusetts, United States
  9. Mozart Therapeutics, IncBoard Member2021 — 2025Seattle, Washington, United States
  10. Deka Biosciences, IncBoard Member2021 — 2025Germantown, Maryland, United States
  11. eGenesis, Inc.Board Member2019 — 2025Cambridge, Massachusetts
  12. Immunitas TherapeuticsBoard Member2019 — 2025Cambridge, Massachusetts
  13. Capstan TherapeuticsBoard Observer2023 — 2025Boston, Massachusetts, United States
  14. NextPoint Therapeutics, Inc.Board Observer2022 — 2025Cambridge, Massachusetts, United States
  15. Boundless BioBoard Observer2023 — 2025San Diego, California, United States
  16. Axxam S.p.ABoard Member2019 — 2022
  17. MetagenomiBoard Observer2020 — 2022
  18. Pyxis OncologyBoard Member2019 — 2021Cambridge, Massachusetts
  19. Silence Therapeutics plcHead of Business Development2015 — 2017London, England, United Kingdom
  20. Silence Therapeutics plcScientific Officer Translational Medicine2014 — 2015London
  21. Imperial College LondonCardiovascular Scientist2011 — 2014Londra, Regno Unito

Skills & more

Cell Biology23Biotechnology22Cell Culture9Genetics8Pharmaceutical Industry9Biochemistry6Pharmacokinetics5Lifesciences5Pharmacology4Drug development4Ricerca4Scienza4
+12 moreGeneticaIndustria farmaceuticaBiochimicaBiotecnologiaBiologia molecolareScienze naturaliIn vitroR&DABPI code of practiceReal TimeStrategiaBloomberg

Languages Inglese · Italiano · Portoguese · Spanish

From Lucio's professional profile.

Colleagues at JDRF T1D Fund

Aaron J. Kowalski
Board of Directors at JDRF T1D Fund
Adam King
Vice President at GroundForce Capital
Brady Bohrmann
Investment Committee at JDRF T1D Fund
Dan McNamara
Head of Strategy & Industry Engagement at JDRF T1D Fund
Daniel Flicker
Senior Associate at JDRF T1D Fund
Elizabeth Mily
CEO at JDRF T1D Fund
Eric Shen
Chief of Staff at JDRF T1D Fund
Ethan Sohn
Principal at Toyota Ventures

Network2

Derek Norman
Vice President at Leaps by Bayer
Fabio Pucci
Partner at Arkin Capital

Investors connected to Lucio in public investor directories — a warm-intro map.

Frequently asked questions

Who is Lucio Iannone?
Lucio Iannone is a Senior Managing Director at T1D Fund, where he focuses on early-stage biotech investments. He works with scientists and entrepreneurs developing medical technologies and therapeutic applications.
Where does Lucio Iannone work?
Lucio Iannone is Managing Director at JDRF T1D Fund and Board director at Affini-T Therapeutics and Board director at Immunitas Therapeutics.
Where did Lucio Iannone go to school?
Lucio Iannone studied at Imperial College London (Doctor of Philosophy (Ph.D.), Medicine); Università degli Studi di Napoli Federico II (Bachelor's degree, Biotechnology).

Same school

Shared employers